======= BRAF ======= == Gene Information == * **Official Symbol**: BRAF * **Official Name**: B-Raf proto-oncogene, serine/threonine kinase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=673|673]] * **UniProt**: [[https://www.uniprot.org/uniprot/P15056|P15056]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BRAF&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BRAF|Open PubMed]] * **OMIM**: [[https://omim.org/entry/164757|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]. * **UniProt Summary**: N/A |C1 1| |Pkinase Tyr| |RBD| |Pkinase| |trehalose metabolism in response to stress| |trehalose metabolic process| |disaccharide metabolic process| |small GTPase binding| |positive regulation of glucose transmembrane transport| |oligosaccharide metabolic process| |regulation of glucose transmembrane transport| |cellular response to calcium ion| |positive regulation of peptidyl-serine phosphorylation| |regulation of peptidyl-serine phosphorylation| |response to calcium ion| |cellular carbohydrate metabolic process| |cellular response to metal ion| |positive regulation of transmembrane transport| |positive regulation of ERK1 and ERK2 cascade| |cellular response to inorganic substance| |protein kinase activity| |establishment of protein localization to membrane| |regulation of ERK1 and ERK2 cascade| |protein serine/threonine kinase activity| |response to metal ion| |MAPK cascade| |signal transduction by protein phosphorylation| |carbohydrate metabolic process| |protein localization to membrane| |response to inorganic substance| |positive regulation of MAPK cascade| |regulation of transmembrane transport| |intracellular membrane-bounded organelle| |calcium ion binding| |regulation of MAPK cascade| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |animal organ morphogenesis| |protein phosphorylation| |positive regulation of transport| |negative regulation of cell death| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |identical protein binding| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of protein modification process| |mitochondrion| |phosphorylation| |regulation of protein phosphorylation| |ATP binding| |regulation of apoptotic process| |regulation of programmed cell death| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| |positive regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.73| ^Gene^Correlation^ |[[:human genes:n:nras|NRAS]]|0.509| |[[:human genes:p:prkce|PRKCE]]|0.486| |[[:human genes:r:raf1|RAF1]]|0.434| |[[:human genes:s:shoc2|SHOC2]]|0.417| Global Fraction of Cell Lines Where Essential: 41/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|1/56| |cervix|0/4| |colorectal|2/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|13/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4083 * **Expression level (log2 read counts)**: 5.54 {{:chemogenomics:nalm6 dist.png?nolink |}}